Back

Prognostic value of liver damage assessed by direct bilirubin and skeletal muscle weakness in patients with heart failure

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Chronic heart failure - Prognosis and prediction of outcome Rehabilitation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Takumi Noda

National Cerebral & Cardiovascular Center, Suita (Japan)

8 More presentations in this session

Presentation thumbnail
National Early Warning Score 2 provides independent prognostic information in patients hospitalized with heart failure with preserved ejection fraction
Doctor K. Berge (Nordbyhagen, NO)
Abstract Slides
Presentation thumbnail
Introduction of a new scoring tool to identify clinically stable heart failure patients
Mr A. Gingele (Maastricht, NL)
Abstract Slides
Presentation thumbnail
A comprehensive study of the incremental prognostic value of novel biomarkers in PARADIGM-HF (Bio-PREDICT-HF)
Doctor K. McDowell (Glasgow, GB)
Abstract Slides
Presentation thumbnail
Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials
Doctor C. Adamson (Larbert, GB)
Abstract Slides
Presentation thumbnail
MR-proADM is a strong independent predictor of long-term all-cause mortality risk in patients with chronic heart failure: results from the E-INH study
Doctor F. Kerwagen (Wuerzburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - Prognosis and prediction of outcome

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Case 1: a patient with ischaemic HFrEF
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Clinical profiles and outcomes of adult patients with heart failure admitted and referred to cardiac rehabilitation in a tertiary national hospital

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources